Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 62, Issue 6
November 2017
Issue Cover
All Issues
ISSN 0009-3157
EISSN 1421-9794

Journal Name Change

Vol. 1-12 (1960-1967) were published under the journal's former title Chemotherapia.

Chemotherapy 2017, Vol. 62, No. 6

Anticancer Section / Original Paper

The Association between Fever and Prognosis in Lung Cancer Patients with Bone Metastases Receiving Zoledronic Acid
Subject Area: Further Areas , Oncology , Pharmacology
Tomiko Sunaga; Kazushi Shimamoto; Shoko Nakamura; Noriko Takahashi; Mayumi Higashino; Tomomi Hozumi; Mitsuki Matsui; Akiko Nagatani; Fumio Kokubu; Mari Kogo; Tadanori Sasaki
Chemotherapy (2017) 62 (6): 327–333. https://doi.org/10.1159/000476055
View articletitled, The Association between Fever and Prognosis in Lung Cancer Patients with Bone Metastases Receiving Zoledronic Acid
Open the PDF for in another window

Anticancer Section / Short Communication

High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy
Subject Area: Further Areas , Oncology , Pharmacology
Pooja Advani; Jonathan Hoyne; Alvaro Moreno-Aspita; Marcia Dubin; Shelly Brock; Caroline Harlow; Saranya Chumsri; Thomas Suter; Joseph L. Blackshear
Chemotherapy (2017) 62 (6): 334–338. https://doi.org/10.1159/000477797
View articletitled, High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy
Open the PDF for in another window

Antimicrobial Section / Short Communication

Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae Clinical Isolates in Bulgaria
Subject Area: Further Areas , Oncology , Pharmacology
Encho Savov; Iva Todorova; Lida Politi; Angelina Trifonova; Maja Borisova; Elena Kioseva; Athanassios Tsakris
Chemotherapy (2017) 62 (6): 339–342. https://doi.org/10.1159/000464275
View articletitled, Colistin Resistance in KPC-2- and SHV-5-Producing <strong><em>Klebsiella pneumoniae</em></strong> Clinical Isolates in Bulgaria
Open the PDF for in another window

Antimicrobial Section / Original Paper

Clinical Manifestations and Prognostic Factors of Pneumocystis jirovecii Pneumonia without HIV
Subject Area: Further Areas , Oncology , Pharmacology
Nobuhiro Asai; Shinji Motojima; Yoshihiro Ohkuni; Ryo Matsunuma; Takuya Iwasaki; Kei Nakashima; Keiji Sogawa; Tamao Nakashita; Norihiro Kaneko
Chemotherapy (2017) 62 (6): 343–349. https://doi.org/10.1159/000477332
View articletitled, Clinical Manifestations and Prognostic Factors of <strong><em>Pneumocystis jirovecii</em></strong> Pneumonia without HIV
Open the PDF for in another window

Anticancer Section / Novel Insights from Clinical Practice

Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib
Subject Area: Further Areas , Oncology , Pharmacology
Ernesto Vigna; Bruno Martino; Francesco Bacci; Anna Grazia Recchia; Francesco Mendicino; Rosellina Morelli; Francesca Romana Mauro; Caterina Musolino; Rosa Greco; Eugenio Lucia; Elena Sabattini; Fortunato Morabito; Massimo Gentile
Chemotherapy (2017) 62 (6): 350–352. https://doi.org/10.1159/000477796
View articletitled, Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib
Open the PDF for in another window
Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant
Subject Area: Further Areas , Oncology , Pharmacology
Annamaria Petrungaro; Massimo Gentile; Carla Mazzone; Rosa Greco; Giuseppina Uccello; Anna Grazia Recchia; Laura De Stefano; Sabrina Bossio; Angela Palummo; Rosellina Morelli; Caterina Musolino; Fortunato Morabito; Ernesto Vigna
Chemotherapy (2017) 62 (6): 353–356. https://doi.org/10.1159/000477714
View articletitled, Ponatinib-Induced Graft-versus-Host Disease/Graft-versus-Leukemia Effect in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia without the T315I Mutation Relapsing after Allogeneic Transplant
Open the PDF for in another window

Anticancer Section / Short Communication

The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung
Subject Area: Further Areas , Oncology , Pharmacology
Masahiro Tsuboi; Chikuma Hamada; Harubumi Kato; Mitsuo Ohta
Chemotherapy (2017) 62 (6): 357–360. https://doi.org/10.1159/000479084
View articletitled, The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung
Open the PDF for in another window

Anticancer Section / Original Paper

Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
Subject Area: Further Areas , Oncology , Pharmacology
Jang Han Jung; Hee Seung Lee; Jung Hyun Jo; In Rae Cho; Moon Jae Chung; Seungmin Bang; Seung Woo Park; Si Young Song; Jeong Youp Park
Chemotherapy (2017) 62 (6): 361–366. https://doi.org/10.1159/000479425
View articletitled, Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer
Open the PDF for in another window

Antimicrobial Section / Novel Insights from Clinical Practice

Severe Drug-Induced Liver Injury as an Adverse Drug Event of Antibiotics: A Case Report and Review of the Literature
Subject Area: Further Areas , Oncology , Pharmacology
Martin Munz; Hans Grummich; Josef Birkmann; Martin Wilhelm; Ulrike Holzgrabe; Fritz Sörgel
Chemotherapy (2017) 62 (6): 367–373. https://doi.org/10.1159/000480399
View articletitled, Severe Drug-Induced Liver Injury as an Adverse Drug Event of Antibiotics: A Case Report and Review of the Literature
Open the PDF for in another window

Anticancer Section / Original Paper

Effectiveness of Nivolumab versus Docetaxel as Second-Line Treatment in Non-Small Cell Lung Cancer Patients in Clinical Practice
Subject Area: Further Areas , Oncology , Pharmacology
Pablo Calpe-Armero; Rafael Ferriols-Lisart; Francisco Ferriols-Lisart; Alejandro Pérez-Pitarch
Chemotherapy (2017) 62 (6): 374–380. https://doi.org/10.1159/000475803
View articletitled, Effectiveness of Nivolumab versus Docetaxel as Second-Line Treatment in Non-Small Cell Lung Cancer Patients in Clinical Practice
Open the PDF for in another window

 

Acknowledgement to Reviewers
Subject Area: Further Areas , Oncology , Pharmacology
Chemotherapy (2017) 62 (6): 381. https://doi.org/10.1159/000478064
View articletitled, Acknowledgement to Reviewers
Open the PDF for in another window
Contents Vol. 62, 2017
Subject Area: Further Areas , Oncology , Pharmacology
Chemotherapy (2017) 62 (6): I–VI. https://doi.org/10.1159/000478065
View articletitled, Contents Vol. 62, 2017
Open the PDF for in another window
Safety and efficacy of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim in Japanese patients with advanced or metastatic urothelial carcinoma
Therapeutic drug monitoring, population pharmacokinetics models and external validation of high-dose methotrexate in pediatric acute lymphoblastic leukemia
Contents Vol. 69, 2024
Time-Kill Curve Analysis of Fucoidan Combination with Conventional Antibiotics against Biofilms Formation of Methicillin-Resistant Staphylococcus aureus and Acinetobacter baumannii Clinical Isolates
  • Online ISSN 1421-9794
  • Print ISSN 0009-3157
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal